MedTrace Logo

The Effect Of Technology Addiction Prevention Program On University Students At Risk For Technology Addiction

NCT06918691 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2026-05-07

No results posted yet for this study

Summary

Due to the increasing use of technological devices among adolescents, technology addiction is a serious public health problem that requires intervention. In order to cope with this problem, it is necessary to develop programs that have proven effects and are suitable for our culture and the psychosocial development of the age group in question. In the project planned to be carried out in two stages, university students at risk of technology addiction will be identified and the effect of the developed technology addiction prevention program will be evaluated. In these days when national combat studies on behavioral addictions are initiated in our country, the results of the research will contribute to the development of national action plans in the fight against technology addiction. The purpose of this doctoral thesis is to evaluate the effect of the technology addiction prevention program for university students at risk of technology addiction.

Conditions

  • Technology Addiction
  • Public Health Nursing
  • School Health

Interventions

BEHAVIORAL

technology addiction prevention program

technology addiction prevention program

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Çiçek ÖNDER · Istanbul University - Cerrahpasa

  • Aysun ARDIÇ · Istanbul University - Cerrahpasa

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-06-30
Completion
2026-01-16

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06918691 on ClinicalTrials.gov